Cholesterol 2001. Rationale for lipid-lowering in older patients with or without CAD

W S Aronow1

  • 1Brookdale Department of Geriatrics and Adult Development, Mount Sinai School of Medicine, New York, USA.

Geriatrics
|October 5, 2001
PubMed

Insights

Statin therapy for individuals over 50 with coronary artery disease and high cholesterol significantly lowers mortality and cardiovascular events. It is also beneficial for older adults without cardiovascular disease but with specific cholesterol levels.

Area of Science:

  • Cardiology
  • Pharmacology
  • Preventive Medicine

Background:

  • Hypercholesterolemia is a significant risk factor for cardiovascular disease (CVD).
  • Older adults with existing CVD or specific risk factors benefit from lipid-lowering therapies.

Purpose of the Study:

  • To evaluate the efficacy of statin treatment in reducing adverse outcomes in older adults.
  • To define target low-density lipoprotein (LDL) cholesterol levels for specific patient populations.

Main Methods:

  • Analysis of outcomes in men and women aged 50 and older treated with statins.
  • Review of LDL cholesterol targets for patients with coronary artery disease (CAD), stroke, peripheral arterial disease, or carotid arterial disease.
  • Assessment of statin effectiveness in older individuals with hypercholesterolemia but no prior CVD.

Main Results:

  • Statin treatment reduces all-cause mortality, cardiovascular mortality, coronary events, revascularization, stroke, and intermittent claudication in older adults with CAD and hypercholesterolemia.
  • Target LDL cholesterol < 100 mg/dL is recommended for older patients with CAD, prior stroke, peripheral arterial disease, or carotid arterial disease and LDL > 125 mg/dL despite diet.
  • Statins effectively reduce cardiovascular events in older persons with hypercholesterolemia but without established CVD.

Conclusions:

  • Statin therapy is a cornerstone in managing hypercholesterolemia and preventing cardiovascular events in older adults.
  • Specific LDL cholesterol targets should guide statin therapy initiation and titration in high-risk older populations.
  • Consider statins for individuals aged 50-80 without CVD but with elevated LDL (>130 mg/dL) and low HDL (<50 mg/dL).

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...